34th week of 2021 patent applcation highlights part 10 |
Patent application number | Title | Published |
20210260050 | AMORPHOUS SOLID DISPERSION COMPRISING 6-(1-ACRYLOYLPIPERIDIN-4-YL)-2-(4-PHENOXYPHENYL)NICOTINAMIDE | 2021-08-26 |
20210260051 | COMBINATION OF EZH2 INHIBITOR AND CHECKPOINT THERAPY FOR THE TREATMENT OF CANCER | 2021-08-26 |
20210260052 | SELECTIVE ESTROGEN RECEPTOR DEGRADERS | 2021-08-26 |
20210260053 | EARLY TREATMENT OF CMT DISEASE | 2021-08-26 |
20210260054 | BUPROPION AS A MODULATOR OF DRUG ACTIVITY | 2021-08-26 |
20210260055 | TOPICAL FORMULATIONS OF DGAT1 INHIBITORS AND THEIR METHODS OF USE | 2021-08-26 |
20210260056 | LOW-DOSE TRIPLE COMBINATION FORMULATION | 2021-08-26 |
20210260057 | COMPOSITIONS AND METHODS TARGETING GLUTAMINE AND ITS METABOLISM FOR DIAGNOSING AND TREATING CANCER AND THERAPY-ASSOCIATED SIDE EFFECTS | 2021-08-26 |
20210260058 | Nilotinib Compositions with Enhanced Solubility | 2021-08-26 |
20210260059 | MDM2 INHIBITORS AND COMBINATIONS THEREOF | 2021-08-26 |
20210260060 | A SUBSTITUTED AMINO-PYRIMIDINE COMPOUND FOR USE IN A METHOD FOR TREATMENT AND PREVENTION OF MULTIPLE SCLEROSIS | 2021-08-26 |
20210260061 | SOLUBILIZED COMPOSITIONS FOR CONTROLLED PROLIFERATION OF STEM CELLS / GENERATING INNER EAR HAIR CELLS USING GSK3 INHIBITORS: I | 2021-08-26 |
20210260062 | Treatment of Female Genital Schistosomiasis | 2021-08-26 |
20210260063 | PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING CANCER COMPRISING KSP INHIBITOR AND MITOSIS INHIBITOR | 2021-08-26 |
20210260064 | POZIOTINIB COMBINATIONS WITH AN ANTI-HER1, HER2 OR HER4 ANTIBODY AND METHODS OF USE THEREOF | 2021-08-26 |
20210260065 | COMPOUNDS HAVING ANTIBACTERIAL ACTIVITY AND METHODS OF USE | 2021-08-26 |
20210260066 | METHOD OF USING MEK INHIBITOR TO PREVENT RADIATION INDUCED FIBROSIS | 2021-08-26 |
20210260067 | HETEROCYCLIC COMPOUNDS, PREPARATION METHODS AND USES THEREOF | 2021-08-26 |
20210260068 | DPP IV INHIBITOR FORMULATIONS | 2021-08-26 |
20210260069 | IRE1a INHIBITOR IN COMBINATION WITH CANCER THERAPEUTIC AGENT FOR CANCER TREATMENT | 2021-08-26 |
20210260070 | LYSIN CF-301 RESENSITIZES METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUA (MRSA) TO PENICILLIN DERIVATIVES AND FIRST GENERATION CEPHALOSPORINS | 2021-08-26 |
20210260071 | AQUEOUS SOLUTION FOR A SURGERY AND METHOD FOR USING THE SAME | 2021-08-26 |
20210260072 | TRIAZOLOBENZAZEPINES AS VASOPRESSIN V1A RECEPTOR ANTAGONISTS | 2021-08-26 |
20210260073 | ORAL QUETIAPINE SUSPENSION FORMULATIONS WITH EXTENDED SHELF LIFE AND ENHANCED BIOAVAILABILITY | 2021-08-26 |
20210260074 | SEIZURE CONTROL COMPOSITIONS AND METHODS OF USING SAME | 2021-08-26 |
20210260075 | OIL-IN-OIL EMULSIFIED POLMERIC IMPLANTS CONTAINING A HYPOTENSIVE LIPID AND RELATED METHODS | 2021-08-26 |
20210260076 | FULVESTRANT FORMULATIONS | 2021-08-26 |
20210260077 | ORAL SOLUTIONS COMPRISING FLUDROCORTISONE ACETATE | 2021-08-26 |
20210260078 | LOW DOSAGE INTRANASAL AMINOSTEROL DOSAGE FORMS AND METHODS OF USING THE SAME | 2021-08-26 |
20210260079 | Adjunctive Therapy With 25-Hydroxyvitamin D And Articles Therefor | 2021-08-26 |
20210260080 | Prenatal Supplement Formulation and Method of Administration | 2021-08-26 |
20210260081 | New Substituted N9-Adenine Derivatives, Pharmaceutical Compositions Containing Same and Use Thereof | 2021-08-26 |
20210260082 | PHOSPHINIC AMIDE PRODRUGS OF TENOFOVIR | 2021-08-26 |
20210260083 | METHODS OF TREATING HEART FAILURE WITH REDUCED EJECTION FRACTION | 2021-08-26 |
20210260084 | PHARMACEUTICAL COMPOSITION COMPRISING DAPAGLIFLOZIN | 2021-08-26 |
20210260085 | COMPOSITION OF ALGINIC OLIGOSACCHARIC DIACIDS | 2021-08-26 |
20210260086 | METHODS OF INHIBITION OF PROTEIN FUCOSYLATION IN VIVO USING FUCOSE ANALOGS | 2021-08-26 |
20210260087 | GLYCOALKALOID COMBINATIONS AND VARIOUS USES THEREOF | 2021-08-26 |
20210260088 | BETALAIN COMPOSITIONS AND METHODS THEREFOR | 2021-08-26 |
20210260089 | USE OF MANNURONIC DIACID COMPOSITION IN TREATMENT OF PARKINSON'S DISEASE | 2021-08-26 |
20210260090 | USE OF SGLT-2 INHIBITORS FOR THE PREVENTION AND/OR TREAT-MENT OF CARDIAC DISEASES IN FELINES | 2021-08-26 |
20210260091 | USE OF SALIDROSIDE AND DERIVATIVE THEREOF IN PREPARATION OF INHIBITOR MEDICAMENT FOR DISEASES OF OPHTHALMIC FIBROSIS CAUSED BY ABNORMALITIES OF EXTRACELLULAR MATRIX PROTEINS | 2021-08-26 |
20210260092 | METHODS AND COMPOSITIONS FOR TREATING AND DIAGNOSING PANCREATIC CANCERS | 2021-08-26 |
20210260093 | RIG-I Agonists and Treatments Using Same | 2021-08-26 |
20210260094 | Polylactose, a prebiotic dietary fiber | 2021-08-26 |
20210260095 | MEDICINE USING HSP47 INHIBITOR TO ENHANCE SENSITIVITY TO CHEMOTHERAPEUTIC AGENT | 2021-08-26 |
20210260096 | PHARMACEUTICAL COMPOSITION FOR TREATING WOUND OR ACTIVATING SKIN, CONTAINING BETA-GLUCAN, GLYCITIN, AND 4',6,7-TRIMETHOXYISOFLAVONE | 2021-08-26 |
20210260097 | METHODS FOR THERAPEUTIC ADMINISTRATION OF MESSENGER RIBONUCLEIC ACID DRUGS | 2021-08-26 |
20210260098 | CELL PROTECTIVE METHODS AND COMPOSITIONS | 2021-08-26 |
20210260099 | Methods for Treating Overweight or Obesity | 2021-08-26 |
20210260100 | GLUCOCEREBROSIDE TREATMENT OF DISEASE | 2021-08-26 |
20210260101 | POTENTIATED ANTIBIOTIC COMPOSITIONS AND METHODS OF USE FOR TREATING BACTERIAL INFECTIONS AND BIOFILMS | 2021-08-26 |
20210260102 | TUNABLE IMMUNE RESPONSIVE BIODEGRADABLE ARGININE-BASED POLY(ESTER AMIDE)S AND METHODS OF MAKING AND USING SAME | 2021-08-26 |
20210260103 | COMPOSITIONS OF AMORPHOUS CALCIUM CARBONATE FOR INHALATION, SUBLINGUAL OR BUCCAL ADMINISTRATION | 2021-08-26 |
20210260104 | SOLUTION FOR PROLONGING OPEN TIME OF FERTILIZATION HOLE OF FISH EGGS AND METHOD FOR INTRODUCING EXOGENOUS GENE THROUGH FERTILIZATION HOLE | 2021-08-26 |
20210260105 | COMPOSITION AND THERAPY FOR TREATMENT OF GAG REFLEXES | 2021-08-26 |
20210260106 | CHLORITE-CONTAINING COMPOSITIONS | 2021-08-26 |
20210260107 | Methods Of Inhibiting Microbial Infections Using Zinc-Containing Compositions | 2021-08-26 |
20210260108 | ZINC-CONTAINING, WATER-SOLUBLE POLYGLUTAMIC ACID COMPLEX COMPOSITION | 2021-08-26 |
20210260109 | Use of Apoptotic Compensatory Proliferation Signaling Vesicles in Tissue Repair and Wound Healing | 2021-08-26 |
20210260110 | NOVEL METHODS FOR THE PRODUCTION OF PHARMACEUTICAL AGENTS | 2021-08-26 |
20210260111 | METHODS FOR GENERATING MACROPHAGES WITH ENHANCED CANCER PHAGOCYTOSIS | 2021-08-26 |
20210260112 | ANIMAL PLASMA OR FRACTIONS THEREOF FOR USE IN TREATING COGNITIVE IMPAIRMENT DISORDERS IN HUMANS AND COMPANION ANIMALS | 2021-08-26 |
20210260113 | DEVICES, METHODS, COMPOSITIONS AND SYSTEMS FOR THE TREATMENT OF AGING AND AGE-RELATED DISORDERS | 2021-08-26 |
20210260114 | CRYOPRECIPITATE COMPOSITIONS AND METHODS OF PREPARATION THEREOF | 2021-08-26 |
20210260115 | MODIFIED NATURAL KILLER CELLS, PHARMACEUTICAL COMPOSITION, MANUFACTURING METHOD THEREOF, AND METHOD OF USING THE SAME | 2021-08-26 |
20210260116 | Chimeric Antigen Receptor-Modified NK-92 Cells | 2021-08-26 |
20210260117 | MODIFIED CELLS AND METHODS OF THERAPY | 2021-08-26 |
20210260118 | BCMA CAR-T CELLS WITH ENHANCED ACTIVITIES | 2021-08-26 |
20210260119 | ENHANCED IMMUNE CELLS USING DUAL SHRNA AND COMPOSITION INCLUDING THE SAME | 2021-08-26 |
20210260120 | PEPTIDES AND COMBINATION OF PEPTIDES OF NON-CANONICAL ORIGIN FOR USE IN IMMUNOTHERAPY AGAINST DIFFERENT TYPES OF CANCERS | 2021-08-26 |
20210260121 | RESTIMULATION OF CRYOPRESERVED TUMOR INFILTRATING LYMPHOCYTES | 2021-08-26 |
20210260122 | NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST EPITHELIAL OVARIAN CANCER AND OTHER CANCERS | 2021-08-26 |
20210260123 | NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST EPITHELIAL OVARIAN CANCER AND OTHER CANCERS | 2021-08-26 |
20210260124 | ANTIBODY CAPABLE OF INDUCING IMMUNE TOLERANCE PRODUCED USING CELL MIXTURE HAVING COMPLEXED STATE, AND INDUCED LYMPHOCYTE OR CELL THERAPEUTIC AGENT AND CELL THERAPY METHOD EACH USING INDUCED LYMPHOCYTE | 2021-08-26 |
20210260125 | ANTI-SLAMF7 CHIMERIC ANTIGEN RECEPTORS | 2021-08-26 |
20210260126 | Methods for the Storage of Whole Blood, and Compositions Thereof | 2021-08-26 |
20210260127 | A THERAPY FOR POLYGLUTAMINE (POLYQ) DISEASES | 2021-08-26 |
20210260128 | NF-KB p50 DEFICIENT IMMATURE MYELOID CELLS AND THEIR USE IN TREATMENT OF CANCER | 2021-08-26 |
20210260129 | Cell Expansion Methods and Therapeutic Compositions | 2021-08-26 |
20210260130 | COMPOSITIONS AND METHODS FOR INHIBITION OF LINEAGE SPECIFIC ANTIGENS | 2021-08-26 |
20210260131 | Sponge patch complex of stem cell preparation for treating brain diseases, preparation method thereof, and application thereof | 2021-08-26 |
20210260132 | A METHOD FOR DIRECT REPROGRAMMING OF URINE CELLS INTO NEURAL STEM CELLS USING SYNTHETIC MRNA | 2021-08-26 |
20210260133 | CARDIAC NEURAL CREST CELLS AND METHODS OF USE THEREOF | 2021-08-26 |
20210260134 | Compositions and Methods for Tissue Repair with Extracellular Matrices | 2021-08-26 |
20210260135 | Production Method for Culture Supernatant Preparation | 2021-08-26 |
20210260136 | Compositions and Methods for Treating Multiple Sclerosis and Related Disorders | 2021-08-26 |
20210260137 | MITOCHONDRIAL AUGMENTATION THERAPY FOR PRIMARY MITOCHONDRIAL DISEASES | 2021-08-26 |
20210260138 | BEE VENOM NANOPARTICLES | 2021-08-26 |
20210260139 | MICROBIOME-BASED DIAGNOSIS, PREDICTION AND TREATMENT OF RELAPSING OBESITY | 2021-08-26 |
20210260140 | NOVEL LACTIC ACID BACTERIA AND USE THEREOF | 2021-08-26 |
20210260141 | MSC- AND EXOSOME-BASED IMMUNOTHERAPY | 2021-08-26 |
20210260142 | COMPOSITIONS BASED ON DIETARY FIBERS AND ESSENTIAL OILS | 2021-08-26 |
20210260143 | MEDIUM CHAIN TRIGLYCERIDE BASED OIL PHASE IN WATER MICROEMULSIONS | 2021-08-26 |
20210260144 | QUININE AND ITS USE TO GENERATE INNATE IMMUNE RESPONSE | 2021-08-26 |
20210260145 | PHARMACEUTICAL COMPOSITION FOR ALLEVIATING EYE FATIGUE, CONTAINING, AS ACTIVE INGREDIENTS, LUTEOLIN-7-O-DIGLUCURONIDE AND APIGENIN-7-O-DIGLUCURONIDE ISOLATED FROM PERILLA FRUTESCENS (L.) BRITTON VAR. ACUTA (THUNB.) KUDO LEAF EXTRACT | 2021-08-26 |
20210260146 | Compositions for preventing or treating diseases or disorders associated with neuro-inflammation, neuro-apoptosis, or neuro-oxidative damage and uses thereof | 2021-08-26 |
20210260147 | MITIGATION OF CHRONIC INFANT MALNUTRITION | 2021-08-26 |
20210260148 | PEPTIDES FOR TREATING MUCOSA | 2021-08-26 |
20210260149 | ANTI-NEURODEGENERATIVE THERAPEUTIC, METHOD OF MANUFACTURE, AND USE | 2021-08-26 |